Neurology Central

MicroRNAs may hold key to early diagnosis in Huntington’s disease

Researchers from Boston University School of Medicine (MA, USA), have identified a novel indicator molecule that may be utilized as a biomarker for Huntington’s disease (HD) in individuals who are carriers but not yet sufferers.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.